BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 12, 2003
View Archived Issues
Gemin X claims novel compounds for cancer, viral infections and autoimmune diseases
Read More
Novel antitumor ecteinascidins reported by Spanish research team
Read More
CV Therapeutics describes novel fatty acid oxidation inhibitors
Read More
New prostanoid EP4 receptor agonists and their use in osteoporosis
Read More
Bayer claims new series of thiazole-based anti-HSV agents
Read More
Novel antibacterial dimeric vancomycin derivatives claimed by Theravance
Read More
New MMP inhibitors for arthritis and other disorders discovered at Leo
Read More
Novel neuraminidase inhibitors in early development at BioCryst
Read More
Two series of PDE4 inhibitors identified by Merck researchers
Read More
Active Biotech reports on recent progress
Read More
Potential use of DX-88 in the treatment of hereditary angioedema
Read More
Good safety and efficacy for INS-37217 in the treatment of perennial allergic rhinitis
Read More
Improved management of malignant liver tumors with ferucarbotran-enhanced MRI
Read More
Sonazoid-enhanced ultrasound reported to improve the detection of liver metastases
Read More
Mepolizumab reported to inhibit eosinophil function in asthma and allergy
Read More
Antiallergic effects of CAT-213 in grass pollen-sensitive subjects
Read More
Telik offers progress report
Read More
NicOx reviews phase II data for AZD-3582
Read More
Velcade NDA granted priority review
Read More
Endovasc plans to file Liprostin IND for diabetic neuropathy
Read More
Viragen's natural interferon alfa approved in South Africa
Read More
Phase II results announced for ISA-247 in psoriasis
Read More
Enrollment completed in phase III trial of Aptosyn/Taxotere in NSCLC
Read More
Gilead's Hepsera approved for marketing in E.U. countries
Read More
Nippon Kayaku to seek marketing clearance for gusperimus in Europe
Read More
SMP-114 now in phase II development in Europe
Read More